Patents Assigned to Kurin, Inc.
  • Patent number: 11963769
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: April 23, 2024
    Assignee: Kurin, Inc.
    Inventors: Bobby E. Rogers, Gino Kang, John Detloff
  • Publication number: 20240122510
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Application
    Filed: May 15, 2023
    Publication date: April 18, 2024
    Applicant: KURIN, INC.
    Inventors: Bobby E. ROGERS, Gino KANG, David Karl STROUP, Jonas Dean COCHRAN, Arthur DEPTALA, John DETLOFF, Lonnie POGUE, Brian MACOWSKI
  • Patent number: 11832944
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: February 24, 2023
    Date of Patent: December 5, 2023
    Assignee: KURIN, INC.
    Inventors: Bobby E. Rogers, Gino Kang, John Detloff
  • Patent number: 11826527
    Abstract: A safety needle assembly includes a housing and a cannula hub connected within a side wall of the housing, a needle connected to the cannula and extending from the cannula hub outward from a proximal end of the housing, and a spring connected with the housing. The assembly includes a barrel connected with the spring and at least partially contained within the housing to least partially cover the cannula hub. The barrel is configured for moving, sliding, traveling, activating, relocating, or transitioning from a first mode in which the barrel is securely retracted and locked at least partially within the housing and the needle extends through an aperture of the barrel and the proximal end of the housing, to a second mode in which the barrel extends from the proximal end and beyond the needle.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: November 28, 2023
    Assignee: KURIN, INC.
    Inventors: Bobby E. Rogers, David Karl Stroup
  • Patent number: 11744494
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: September 5, 2023
    Assignee: KURIN, INC.
    Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
  • Publication number: 20230210422
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Application
    Filed: February 24, 2023
    Publication date: July 6, 2023
    Applicant: Kurin, Inc.
    Inventors: Bobby E. ROGERS, Gino KANG, John DETLOFF
  • Publication number: 20230191033
    Abstract: Disclosed are systems that include a syringe having a barrel configured to hold a fluid and a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel. The syringe is configured to inhibit forward movement of the plunger. For example, the systems can include mating pockets configured to engage barbs to inhibit forward movement of the plunger.
    Type: Application
    Filed: December 16, 2022
    Publication date: June 22, 2023
    Applicant: Kurin, Inc.
    Inventors: Kevin NASON, Jeffrey VELOZ, Bobby E. ROGERS, Nolan Leendert PUPPING
  • Publication number: 20230109255
    Abstract: A safety needle assembly includes a housing defining a cavity and having a button, a hub positioned in the cavity, and a needle connected with a distal face of the hub to extend out of the housing. The assembly includes a shield positioned in the cavity having a retracted mode in which the shield is retracted into the housing to expose the needle, and a securement mode in which the shield is extended over a distal end of the needle to cover the needle. A spring connects between the hub and the shield and is configured to transition the shield from the retracted mode to the securement mode. The assembly includes a lock-in mechanism configured to releasably maintain the shield in the retracted mode, and a lock-out mechanism configured to securely maintain the shield in the securement mode.
    Type: Application
    Filed: October 8, 2022
    Publication date: April 6, 2023
    Applicant: Kurin, Inc.
    Inventors: Bobby E. ROGERS, Kevin NASON
  • Patent number: 11617525
    Abstract: A blood sequestration device includes an inlet path, an outlet path, a sequestration chamber, and a sampling channel. The sequestration chamber is connected with the inlet path by a junction and is configured to receive a first portion of blood through the inlet path. The sequestration chamber has a vent that allows air to be displaced by the first portion of blood, the junction being configured to inhibit a return to the inlet path of any of the first portion of blood received by the sequestration chamber. The sampling channel is connected between the inlet path and the outlet path, and configured to convey subsequent amounts of blood between the inlet path and the outlet path after the first amount of blood is received by the sequestration chamber.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: April 4, 2023
    Assignee: KURIN, INC.
    Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski, Kevin Nason
  • Patent number: 11311219
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: April 26, 2022
    Assignee: Kurin, Inc.
    Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
  • Publication number: 20220079483
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 17, 2022
    Applicant: Kurin, Inc.
    Inventors: Bobby E. ROGERS, Gino KANG, John DETLOFF
  • Patent number: 11185266
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: November 30, 2021
    Assignee: Kurin, Inc.
    Inventors: Bobby E. Rogers, Gino Kang, John Detloff
  • Patent number: 10959655
    Abstract: A device and method yielding a blood analysis employable in combination with an introducer for a catheter for a concurrent testing of blood from the introducer flash chamber during placement of a venous catheter. The device employs a colorimetric blood analysis to provide the user a visually discernable alert to the results of tested blood concurrent with the placement of the catheter with the introducer.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: March 30, 2021
    Assignee: Kurin, Inc.
    Inventors: Chad Garrett, John W. Simpson
  • Patent number: 10827964
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: November 10, 2020
    Assignee: Kurin, Inc.
    Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski, Chad Garrett
  • Publication number: 20200281514
    Abstract: A blood sequestration device includes an inlet path, an outlet path, a sequestration chamber, and a sampling channel. The sequestration chamber is connected with the inlet path by a junction and is configured to receive a first portion of blood through the inlet path. The sequestration chamber has a vent that allows air to be displaced by the first portion of blood, the junction being configured to inhibit a return to the inlet path of any of the first portion of blood received by the sequestration chamber. The sampling channel is connected between the inlet path and the outlet path, and configured to convey subsequent amounts of blood between the inlet path and the outlet path after the first amount of blood is received by the sequestration chamber.
    Type: Application
    Filed: March 13, 2020
    Publication date: September 10, 2020
    Applicant: Kurin, Inc.
    Inventors: Bobby E. ROGERS, Gino KANG, David Karl STROUP, Jonas Dean COCHRAN, Arthur DEPTALA, John DETLOFF, Lonnie POGUE, Brian MACOWSKI, Kevin Nason
  • Publication number: 20190030293
    Abstract: A safety needle assembly includes a housing and a cannula hub connected within a side wall of the housing, a needle connected to the cannula and extending from the cannula hub outward from a proximal end of the housing, and a spring connected with the housing. The assembly includes a barrel connected with the spring and at least partially contained within the housing to least partially cover the cannula hub. The barrel is configured for moving, sliding, traveling, activating, relocating, or transitioning from a first mode in which the barrel is securely retracted and locked at least partially within the housing and the needle extends through an aperture of the barrel and the proximal end of the housing, to a second mode in which the barrel extends from the proximal end and beyond the needle.
    Type: Application
    Filed: July 25, 2018
    Publication date: January 31, 2019
    Applicant: KURIN, INC.
    Inventors: Bobby E. ROGERS, David Karl STROUP
  • Patent number: 10143412
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: December 4, 2018
    Assignee: KURIN, INC.
    Inventors: Bobby E. Rogers, Gino Kang, John Detloff
  • Patent number: 10143413
    Abstract: A device and method yielding a blood analysis employable in combination with an introducer for a catheter for a concurrent testing of blood from the introducer flash chamber during placement of a venous catheter. The device employs a colorimetric blood analysis to provide the user a visually discernable alert to the results of tested blood concurrent with the placement of the catheter with the introducer.
    Type: Grant
    Filed: October 16, 2014
    Date of Patent: December 4, 2018
    Assignee: KURIN, INC.
    Inventors: Chad Garrett, John W. Simpson
  • Publication number: 20180289304
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Application
    Filed: May 31, 2018
    Publication date: October 11, 2018
    Applicant: KURIN, INC.
    Inventors: Bobby E. Rogers, Gino Kang, John Detloff
  • Publication number: 20180271425
    Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.
    Type: Application
    Filed: February 9, 2018
    Publication date: September 27, 2018
    Applicant: Kurin, Inc.
    Inventors: Bobby E. ROGERS, Gino KANG, David Karl STROUP, Jonas Dean COCHRAN, Arthur DEPTALA, John DETLOFF, Lonnie POGUE, Brian MACOWSKI, Chad GARRETT